FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

41487911000001106: Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2882471000001116 Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2882481000001119 Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Pirfenidone 267mg tablets true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Pirfenidone true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 252 tablet 18 x 14 tablets Has AMP True Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier
Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) 63 tablet 9 x 7 tablets Has AMP True Pirfenidone 267mg tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start